GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI International Medical Inc (NAS:BIMI) » Definitions » Enterprise Value

BIMI International Medical (BIMI International Medical) Enterprise Value : $22.58 Mil (As of May. 22, 2024)


View and export this data going back to 2006. Start your Free Trial

What is BIMI International Medical Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, BIMI International Medical's Enterprise Value is $22.58 Mil. BIMI International Medical's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-11.14 Mil. Therefore, BIMI International Medical's EV-to-EBIT ratio for today is -2.03.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, BIMI International Medical's Enterprise Value is $22.58 Mil. BIMI International Medical's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-10.88 Mil. Therefore, BIMI International Medical's EV-to-EBITDA ratio for today is -2.08.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, BIMI International Medical's Enterprise Value is $22.58 Mil. BIMI International Medical's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $12.63 Mil. Therefore, BIMI International Medical's EV-to-Revenue ratio for today is 1.79.


BIMI International Medical Enterprise Value Historical Data

The historical data trend for BIMI International Medical's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIMI International Medical Enterprise Value Chart

BIMI International Medical Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 118.97 28.88 27.22 25.95 8.92

BIMI International Medical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.88 8.92 6.68 12.88 15.39

Competitive Comparison of BIMI International Medical's Enterprise Value

For the Pharmaceutical Retailers subindustry, BIMI International Medical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIMI International Medical's Enterprise Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BIMI International Medical's Enterprise Value distribution charts can be found below:

* The bar in red indicates where BIMI International Medical's Enterprise Value falls into.



BIMI International Medical Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

BIMI International Medical's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as

BIMI International Medical's Enterprise Value for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BIMI International Medical  (NAS:BIMI) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

BIMI International Medical's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=22.584/-11.142
=-2.03

BIMI International Medical's current Enterprise Value is $22.58 Mil.
BIMI International Medical's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.14 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

BIMI International Medical's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=22.584/-10.876
=-2.08

BIMI International Medical's current Enterprise Value is $22.58 Mil.
BIMI International Medical's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.88 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

BIMI International Medical's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=22.584/12.633
=1.79

BIMI International Medical's current Enterprise Value is $22.58 Mil.
BIMI International Medical's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BIMI International Medical Enterprise Value Related Terms

Thank you for viewing the detailed overview of BIMI International Medical's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


BIMI International Medical (BIMI International Medical) Business Description

Traded in Other Exchanges
N/A
Address
Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010
BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.
Executives
Ang Sammi Ean Seok director 2658 VISTA MONTE CIRCLE, CHINO HILLS CA 91709
Fnu Oudom director 7700 IRVINE CENTRE DRIVE, SUITE 800, IRVINE CA 92618
Xiaoping Wang director ROOM 4-6,NO.88-4 HUAYAN FIRST VILLAGE, SHAPINGBA DISTRICT, CHONGQING F4 400037
Baiqun Zhong officer: CFO 1-7, NO.27, HUAYAN NEW VILLAGE, JIULONGPO DISTRICT, CHONGQING F4 400039
Zhang Tingting director, officer: Chief Financial Officer 3708, FULI CENTER, NO.6 GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001
Song Tiewei director 17 FLOOR, FULI CENTER NO.6,GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001
Yongquan Bi 10 percent owner ROOM 3708, WANDA PLACE, 6 GANGWAN ROAD, ZHONGSHAN DISTRICT, DALIAN CITY, LIAONING PROVINCE F4 116001
Wang Lihua director, 10 percent owner, officer: Chief Financial Officer NO 4 4 12 58 BAJING ROAD, HEPING DISTRICT SHENYANG CITY, LIAONING PROVINCW F4 110003
Li Gang director, 10 percent owner, officer: President and CEO 19B3 62 WEST HINHE ROAD, SHENHE DISTRICT SHENYANG CITY, LIAONING PROVINCE F4 110000
Jiuding Yan director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Lesley Jin director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Maclean John Coleman director 112 E 4TH AVE, SUITE 206, OLYMPIA WA 98501
Zhongmin Wang director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Jianxin Wang director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021
Mia Kuang Ching director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021

BIMI International Medical (BIMI International Medical) Headlines

From GuruFocus

BIMI Announces 1-for -10 Reverse Stock Split

By Value_Insider Value_Insider 12-08-2022

BIMI Announces Appointment of New Chairman and Independent Director

By GuruFocusNews GuruFocusNews 06-07-2022

BIMI Announces Appointment of Mr. Fnu Oudom to Board of Directors

By GuruFocusNews GuruFocusNews 06-11-2022

BIMI Announces Entering into a $5 million Stock Purchase Agreement

By GuruFocusNews GuruFocusNews 07-10-2022

BIMI to Hold Annual Shareholder Meeting on July 13, 2022

By GuruFocusNews GuruFocusNews 06-28-2022

BIMI Announces Appointment of New Chairman and Independent Director

By GuruFocusNews GuruFocusNews 07-07-2022

BIMI Announces Appointment of New Chairman and Independent Director

By GuruFocusNews GuruFocusNews 05-28-2022

BIMI Announces Entering into a $5 million Stock Purchase Agreement

By GuruFocusNews GuruFocusNews 06-10-2022

BIMI Announces Appointment of Mr. Fnu Oudom to Board of Directors

By GuruFocusNews GuruFocusNews 05-12-2022